Using data from food challenges to inform management of consumers with food allergy: A systematic review with individual participant data meta-analysis.

Journal Information

Full Title: J Allergy Clin Immunol

Abbreviation: J Allergy Clin Immunol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Allergy and Immunology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosure of potential conflict of interest: K. Anagnostou reports personal fees from regional and national allergy societies (American College of Allergy, Asthma and Immunology, Eastern Allergy Conference, the Colorado Allergy and Asthma Society, and The Animal Awareness Society) and grants from Aimmune Therapeutics outside the submitted work. D. C. Adelman and A. D. Smith are employees of Aimmune Therapeutics, a Nestlé Health Science Company. J. L. Baument reports personal fees from DBV Technologies and Neogen Corporation outside the submitted work. W. M. Blom reports funding from the Dutch Ministry of Economic Affairs. D. E. Campbell is a part-time employee of DBV Technologies and reports receiving grant support from the National Health and Medical Research Council of Australia and personal fees from Allergenis, Westmead Fertility Centre, and Financial Markets Foundation for Children. R. S. Chinthrajah receives grants from the National Institute of Allergy and Infectious Disease, Consortium for Food Allergy Research, Aimmune Therapeutics, DBV Technologies, Astellas, and Regeneron and is an advisory member for Alladapt, Genentech, Novartis, and Sanofi. B. Javed is a part-time employee of the UK Food Standards Agency but has contributed to this work in her role at the University of Manchester. H. A. Sampson is a part-time employee of DBV Technologies and reports receiving consultancy fees from N-Fold Therapeutics, grant funding from the National Institutes of Health/National Institute of Allergy and Infectious Disease and royalties from Elsevier. E. N. C. Mills reports grants from the UK Biological and Biotechnological Sciences Research Council, DBV Technologies, Reacta Biotech, the Medical Research Council, the European Union, and the UK Food Standards Agency and has patents pending to Reacta Biotech Ltd (PCT/GB2016/051637 and PCT/GB2016/053829). B. C. Remington reports grants and personal fees from DBV Technologies and travel support from International Life Sciences Institute Europe. P. J. Turner reports grants from the UK Medical Research Council, National Institute for Health Research/Imperial Biomedical Researh Centre, and JM Charitable Foundation during the conduct of the study, as well as personal fees from UK Food Standards Agency, Aimmune Therapeutics, Allergenis, and the International Life Sciences Institute Europe outside the submitted work. The rest of the authors declare that they have no relevant conflicts of interest."

Evidence found in paper:

"Funded in part by a UK Medical Research Council Clinician Scientist award to P.J.T. (reference MR/K010468/1). N.P. and P.J.T. are supported through the National Institute for Health Research Biomedical Research Centre based at Imperial College Healthcare National Health Service Trust and Imperial College London. The views expressed in this article are those of the authors and do not necessarily reflect those of the National Health Service, National Institute for Health Research, the Department of Health, or the Food Standards Agency."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025